A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs
-
Published:2018-10
Issue:
Volume:
Page:
-
ISSN:2055-2173
-
Container-title:Multiple Sclerosis Journal - Experimental, Translational and Clinical
-
language:
-
Short-container-title:
您需要登录后可以查看相关数据！